Patent 8700161 was granted and assigned to MetaCure on April, 2014 by the United States Patent and Trademark Office.
A method of glucose level control, comprising providing at least one electrode adapted to apply an electric field to a pancreas; and applying an electric field to the pancreas using the above-mentioned at least one electrode such that blood glucose levels are significantly reduced and blood insulin levels are not significantly increased.